New Developments in Epigenetics and Potential Clinical Applications


The aim of this evaluation form is to gain your feedback, in order to maintain high educational standards and provide a reference for continuous improvement. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did this E-Learning provide an update on how epigenetic mechanisms regulate gene expression and consequences of abnormal epigenetic regulation in cancer? (1: no, not at all; 5: yes, absolutely)

2. Did this E-Learning allow you to understand that critical epigenetic regulators are often altered or mutated in cancer and thus represent targets for anticancer therapy? (1: no, not at all; 5: yes, absolutely)

3. Did this E-Learning provide an update from clinical studies findings with epigenetic drugs, current list of epigenetic drugs approvals and indications for cancer treatment, as well as perspective of epigenetic drugs still in development? (1: no, not at all; 5: yes, absolutely)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-absolutely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. Do you think that the scientific content of this E-learning activity contains any commercial material?

9. If you answered YES, please motivate your choice in the box below:

10. If you would like to add your personal comments or make suggestion to improve future ESMO E-Learning material, please write in the box below: